🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

4,589 results for “Pharma” Clear

  1. FYU-981

    Mochida Pharmaceutical Company,

    Healthy

    phase 1 small molecule completed

    1 trial

  2. Famciclovir 500 mg Tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  3. Ferumoxytol

    LIPELLA PHARMACEUTICALS INC.

    IC - Interstitial Cystitis

    phase 1 small molecule completed

    1 trial

  4. Fexofenadine

    LEXICON PHARMACEUTICALS, INC.

    Drug Interactions

    phase 1 small molecule completed

    1 trial

  5. Fexofenadine 180 mg tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  6. Filgrastim

    Rocket Pharmaceuticals B.V.

    Fanconi Anemia

    phase 1 mab terminated

    1 trial

  7. Finasteride 5 mg tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  8. Firibastat

    Quantum Biopharma

    Healthy Males

    phase 1 small molecule completed

    1 trial

  9. First in human, Phase 1a/1b Study of KM-023 in healthy volunteers and Olmsted syndrome patients

    Lacuna Pharma Pty Ltd

    Olmsted syndrome

    phase 1 other active

    1 trial

  10. First-in-Human Study of ALN-SNCA in Adult Participants with Early Parkinson’s Disease (PD)

    Lacuna Pharma Pty Ltd

    Parkinson's disease

    phase 1 other active

    1 trial

  11. First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants with Atopic Dermatitis

    Lacuna Pharma Pty Ltd

    Atopic Dermatits

    phase 1 other active

    1 trial

  12. First-in-human Phase 1 Study to Assess the Safety, Tolerability, and Immunogenicity of the Adjuvanted Universal Influenza Vaccine “fH1/DSP-0546LP” in Healthy Adults

    Lacuna Pharma Pty Ltd

    Influenza

    phase 1 other active

    1 trial

  13. Fluconazole

    ENANTA PHARMACEUTICALS INC

    NASH - Nonalcoholic Steatohepatitis

    phase 1 small molecule completed

    1 trial

  14. Fluoxetine Hydrochloride

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  15. Fluticasone Propionate MDPI

    Teva Pharma GmbH

    Asthma

    phase 1 small molecule completed

    1 trial

  16. Fostamatinib

    RIGEL PHARMACEUTICALS INC

    Chronic Graft Versus Host Disease

    phase 1 small molecule active

    1 trial

  17. Fostamatinib 100 mg bid and Paclitaxel

    RIGEL PHARMACEUTICALS INC

    Ovarian Cancer

    phase 1 small molecule completed

    1 trial

  18. Fostamatinib in combination with chemotherapy (gemcitabine and nab-paclitaxel)

    RIGEL PHARMACEUTICALS INC

    Pancreatic Ductal Adenocarcinoma (PDAC)

    phase 1 other active

    1 trial

  19. Freethiadine tablets(part I)

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Hepatitis B, Chronic

    phase 1 small molecule completed

    1 trial

  20. Furmonertinib

    ArriVent BioPharma

    Non-Small Cell Lung Cancer (NSCLC)

    phase 1 small molecule active

    1 trial

  21. GC1102

    Green Valley (Shanghai) Pharmaceuticals Co.,

    Hepatitis B

    phase 1 mab completed

    1 trial

  22. GHB01L1

    Atea Pharmaceuticals

    Seasonal Human Influenza

    phase 1 mab completed

    1 trial

  23. GHB04L1

    Atea Pharmaceuticals

    Influenza, Avian

    phase 1 mab completed

    1 trial

  24. GHB04L1

    Atea Pharmaceuticals

    Influenza

    phase 1 mab completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources